| Bioactivity | BPR1M97 is a dual-acting mu opioid receptor (MOP) and nociceptin-orphanin FQ peptide (NOP) receptor agonist with Ki values of 1.8 and 4.2 nM, respectively. BPR1M97 shows high potency and blood-brain barrier penetration, and produces potent antinociceptive effects[1]. | ||||||||||||
| Target | Ki: 1.8 nM (MOP), 4.2 nM (NOP) | ||||||||||||
| In Vivo | BPR1M97 (1.8 mg/kg; s.c.; once) demonstrates antinociception in a murine model of cancer pain[1]. Animal Model: | ||||||||||||
| Name | BPR1M97 | ||||||||||||
| CAS | 2059904-66-2 | ||||||||||||
| Formula | C18H18Cl2N2O | ||||||||||||
| Molar Mass | 349.25 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Chao PK, et al. BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, producespotent antinociceptive effects with safer properties than morphine. Neuropharmacology. 2019 Jul 3:107678. |
BPR1M97
CAS: 2059904-66-2 F: C18H18Cl2N2O W: 349.25
BPR1M97 is a dual-acting mu opioid receptor (MOP) and nociceptin-orphanin FQ peptide (NOP) receptor agonist with Ki valu
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.